Quick Takeaways
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G for VISTAGEN THERAPEUTICS, INC. Common Stock (VTGN).
- Disclosed ownership: 14%.
- Date of event: 29 Aug 2025.
JANUS HENDERSON GROUP PLC - 29 Aug 2025 SCHEDULE 13G Report for VISTAGEN THERAPEUTICS, INC. Common Stock (VTGN)
- Filing Manager
- JANUS HENDERSON GROUP PLC
- Reporting Manager
- JANUS HENDERSON GROUP PLC
- Symbol
- VTGN
- Shares outstanding
- 30,630,640 shares
- Disclosed Ownership
- 4,165,767 shares
- Ownership
- 14%
- Form type
- SCHEDULE 13G
- Filing time
- 08 Sep 2025, 13:07:37 UTC
- Date of event
- 29 Aug 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"JANUS HENDERSON GROUP PLC disclosed 14% ownership in VISTAGEN THERAPEUTICS, INC. Common Stock (VTGN) on 29 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 08 Sep 2025, 13:07.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 14% | 4,165,767 | 0 | 4,165,767 | Kristin Mariani | Head of North America Compliance, CCO | |
| Janus Henderson Biotech Innovation Master Fund Ltd | 12% | 3,575,276 | 0 | 3,575,276 | Kristin Mariani | Head of North America Compliance, CCO |